Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings.

Sunshine J, Shaffer M, Han LL, Gaikwad D, Houana AA, Gler MT, Hadinegoro SR, Hanekom WA, Lama JR, Muyoyeta M, Musala S, Nduba V, Rolla VC, Roy T, Sutherland JS, Khosa C, Wajja A, Walker TM, Cinar A, Schmidt AC, Dagnew AF, Frahm N, for TBV02-E01 Study Group, for TBV02-E01 Study Group

Open source

DOI: 10.1093/ofid/ofag437
Published: 2026 Jul
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag437,
  title = {Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings.},
  author = {Sunshine J and Shaffer M and Han LL and Gaikwad D and Houana AA and Gler MT and Hadinegoro SR and Hanekom WA and Lama JR and Muyoyeta M and Musala S and Nduba V and Rolla VC and Roy T and Sutherland JS and Khosa C and Wajja A and Walker TM and Cinar A and Schmidt AC and Dagnew AF and Frahm N and for TBV02-E01 Study Group and for TBV02-E01 Study Group},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag437},
  url = {https://doi.org/10.1093/ofid/ofag437}
}

RIS

TY  - JOUR
TI  - Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings.
AU  - Sunshine J
AU  - Shaffer M
AU  - Han LL
AU  - Gaikwad D
AU  - Houana AA
AU  - Gler MT
AU  - Hadinegoro SR
AU  - Hanekom WA
AU  - Lama JR
AU  - Muyoyeta M
AU  - Musala S
AU  - Nduba V
AU  - Rolla VC
AU  - Roy T
AU  - Sutherland JS
AU  - Khosa C
AU  - Wajja A
AU  - Walker TM
AU  - Cinar A
AU  - Schmidt AC
AU  - Dagnew AF
AU  - Frahm N
AU  - for TBV02-E01 Study Group
AU  - for TBV02-E01 Study Group
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag437
UR  - https://doi.org/10.1093/ofid/ofag437
ER  -

APA

J, S., M, S., LL, H., D, G., AA, H., MT, G., SR, H., WA, H., JR, L., M, M., S, M., V, N., VC, R., T, R., JS, S., C, K., A, W., TM, W., A, C., AC, S., AF, D., N, F., Group, F. T. S., & Group, F. T. S. (2026). Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag437

Source records

pubmed · retrieved 2026-09-27T07:28:13.364Z